Toronto February 22, 2021

Skin Cancer: How to Facilitate Early Diagnosis and Treatment

Melanoma Network of Canada (MNC) is proud to announce the launch of a Continuing Medical Education (CME) Certified course to support primary care physicians in triaging skin lesions more accurately and at an earlier stage, with a focus on recognizing suspicious skin lesions and selecting which biopsy would be most appropriate based on physical characteristics of the suspicious lesion.

This self-learning program has been certified by the College of Family Physicians of Canada and is offered through MDBriefCase Group Inc. MDBriefCase provides accredited, online continuing professional development (CPD) to help healthcare practitioners enhance their professional practice and stay at the forefront of the latest evidence and protocols.

“As front line physicians in detecting skin cancer, this accredited CME course offers a very timely and innovative program for our primary care partners. Melanoma, a potentially deadly skin cancer, can typically be cured when identified and treated early. This program provides primary care physicians with the expertise to diagnose and biopsy suspicious lesions, critical steps to improving outcomes in our patients with skin cancer. I am grateful to the Melanoma Network of Canada for sponsoring this essential program in conjunction with MD Briefcase.” – Elaine McWhirter, MD, MSc, FRCPC

MNC is grateful to the course planning committee of leading skin cancer and medical professionals:

Dr. Margaret Redpath, MD, PhD,
Dr. Elaine McWhirter, MD, MSc, FRCPC
Dr. Yevgeny Filanovsky, MD, CCFP (EM), MMED(SC),
Dr. Sofia Nastis, MD, CCFP,
Dr. Darshini Persaude, MD, CCFP

Improving Patient Outcomes

Melanoma Network of Canada’s continued mission is to support melanoma patients, caregivers and medical professionals through current and coordinated information and services. Skin cancer is the most common type of cancer, with a rising incidence of both melanoma and non-melanoma skin cancer. Non-melanoma skin cancer is the most common cancer diagnosed in Canadians, but specific statistics are not reported as these cancers are difficult to track. In 2020, an estimated 8,000 Canadians will be diagnosed with melanoma and 1,300 Canadians will die from the disease. Primary care physicians can improve patient outcomes by facilitating early skin cancer diagnosis and management.

“MNC is proud to launch this groundbreaking course in partnership with MD Briefcase. It is a crucial step toward improving patient outcomes. Early diagnosis is key to survival. In many parts of the country, delays to see a dermatologist can be overwhelming. With the knowledge gained from this course, primary care practitioners will be able to better diagnose, treat, and manage skin cancer. We are grateful for the support of our corporate partners without whom this course would not be possible.” Falyn Katz, Executive Director – Melanoma Network of Canada

Learning objectives

Upon completion of this continuing education program, participants will be better able to:

  • Recognize and clinically diagnose skin cancers.
  • Select which biopsy would be appropriate to perform on a suspicious skin lesion.
  • Describe the available treatment options for different types of skin cancer.
  • Apply their knowledge to enable earlier diagnosis and management of patients with skin cancer.

For More Information Please Visit MDBC.me/Skin-cancer

This 1-credit-per-hour Self-Learning program has been certified by the College of Family Physicians of Canada for up to 1 Mainpro+ Credit. Cert+ Program ID#: 193815

Thank you to our partners

This program was made possible by the generous support of our partners Bristol Myers Squibb, Johnson & Johnson, Merck Canada, and Novartis Canada.

About MNC

The Melanoma Network of Canada (MNC) was founded in 2009, to respond to the need for patients in Canada to have a nationally-based organization to coordinate education and prevention efforts raising awareness, provide a strong voice for advocacy, and to provide support services and programs for melanoma and non-melanoma skin cancer patients and caregivers.

MNC works tirelessly to develop and implement programs, and offer services to meet the needs and missing gaps for melanoma and non-melanoma skin cancer patients and their caregivers during initial diagnosis, treatment, and recurrence stages.  

CONTACT

Mary Zawadzki – Patient Care Specialist, B.A, SSW, RSSW Member of CAPO
mzawadzki@melanomanetwork.ca
905.901.5121 | 1.877.560.8035 x 108
482 South Service Rd E. Unit 110 Oakville, Ontario, L6J 2X6  


Raising awareness and prevention through Education, Advocacy and Research. Check your skin monthly. Business registration: 85491 3050 RR0001